The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-(((2-(1H-indol-2-yl)ethyl)(2-hydroxyethyl)amino)methyl)phenyl)-N-hydroxyacrylamide ID: ALA403323
Cas Number: 591207-53-3
PubChem CID: 44456564
Max Phase: Preclinical
Molecular Formula: C22H25N3O3
Molecular Weight: 379.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(/C=C/c1ccc(CN(CCO)CCc2cc3ccccc3[nH]2)cc1)NO
Standard InChI: InChI=1S/C22H25N3O3/c26-14-13-25(12-11-20-15-19-3-1-2-4-21(19)23-20)16-18-7-5-17(6-8-18)9-10-22(27)24-28/h1-10,15,23,26,28H,11-14,16H2,(H,24,27)/b10-9+
Standard InChI Key: FGJCGXHQLHHNFO-MDZDMXLPSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
7.8618 -6.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2446 -7.1769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0694 -7.2111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3010 -5.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1246 -5.7782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5122 -6.5081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3262 -6.3650 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4416 -5.5466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6990 -5.1840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1703 -5.1596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8697 -5.5971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5983 -5.2101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2977 -5.6476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6275 -4.3856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3561 -3.9986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3852 -3.1741 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0264 -5.2606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7226 -5.7010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4507 -5.3147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4803 -4.4893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7759 -4.0518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0506 -4.4406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2084 -4.1013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9084 -4.5379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6365 -4.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3366 -4.5865 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6646 -3.3254 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0647 -4.1986 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3 6 2 0
12 14 1 0
1 2 2 0
14 15 1 0
5 4 2 0
15 16 1 0
6 7 1 0
13 17 1 0
7 8 1 0
17 18 2 0
8 9 2 0
18 19 1 0
9 5 1 0
19 20 2 0
4 1 1 0
20 21 1 0
8 10 1 0
21 22 2 0
22 17 1 0
5 6 1 0
20 23 1 0
10 11 1 0
23 24 2 0
24 25 1 0
11 12 1 0
25 26 1 0
2 3 1 0
25 27 2 0
12 13 1 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.46Molecular Weight (Monoisotopic): 379.1896AlogP: 2.72#Rotatable Bonds: 9Polar Surface Area: 88.59Molecular Species: BASEHBA: 4HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.66CX Basic pKa: 8.89CX LogP: 1.98CX LogD: 0.78Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.26Np Likeness Score: -0.62
References 1. Paris M, Porcelloni M, Binaschi M, Fattori D.. (2008) Histone deacetylase inhibitors: from bench to clinic., 51 (6): [PMID:18247554 ] [10.1021/jm7011408 ]